Health ❯Healthcare ❯Public Health ❯Infectious Diseases

HIV/AIDS

Monthly Oral PrEP Candidate MK-8527 Shows Early Promise in Merck Study

The PLOS Biology paper outlines preclinical results with early safety signals that support a once-monthly dosing strategy.

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Judge Allows Trump Administration to Continue Overhaul of USAID

Lenacapavir Injection Offers Breakthrough in HIV Prevention

Global HIV Infections and Deaths Reach Historic Lows, UNAIDS Warns Progress Too Slow

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV